文献速递间质性肺疾病

间质性肺异常与死亡率及多病共存的关系:一项队列研究

The relationship between interstitial lung abnormalities, mortality, and multimorbidity: a cohort study.
PubMed 文献 · Thorax · 2022-07-01

该研究在FHS(n=2449)和AGES-Reykjavik(n=5180)两个观察性队列中,通过盲法CT判读评估间质性肺异常(ILA),分析其与全因死亡率的关联,并调整多病共存因素。结果显示ILA与死亡率显著相关(FHS:HR 1.95,95%CI 1.23-3.08,p=0.0042;AGES-Reykjavik:HR 1.60,95%CI 1.41-1.82,p<0.0001),且其死亡风险增幅与多种常见慢性病相似。

要点

  • ILA在调整多病共存后仍与全因死亡率显著相关。
  • ILA相关的死亡风险与心血管病、糖尿病等常见慢性病相似。
  • ILA与这些慢性病本身的患病率无一致关联。

核心结论

  • ILA与全因死亡率相关,且独立于多病共存。
  • ILA与死亡率的关联强度与几种常见慢性病相似。
  • ILA与这些慢性病本身的患病率无一致关联。

研究设计与样本

  • 研究为两个观察性队列:FHS(n=2449)和AGES-Reykjavik(n=5180)。
  • 通过盲法CT判读评估ILA(无、不确定、确定)。
  • 采用Cox比例风险模型分析死亡率关联,多项逻辑回归分析ILA与疾病关联。

主要发现

  • FHS中位随访8.8年(IQR 1.4),AGES-Reykjavik中位随访12.0年(IQR 7.7)。
  • 调整多病共存后,ILA与死亡率显著相关:FHS HR 1.95(95%CI 1.23-3.08,p=0.0042);AGES-Reykjavik HR 1.60(95%CI 1.41-1.82,p<0.0001)。
  • 两个队列中,ILA与死亡率的关联强度与多数其他疾病相似。
  • 调整模型中,FHS中ILA仅与肾病患病相关(OR 1.90,95%CI 1.01-3.57,p=0.0452);AGES-Reykjavik中ILA与CVD患病相关(OR 1.42,95%CI 1.12-1.81,p=0.0040)。

临床怎么用

  • CT上发现ILA应视为死亡风险增加的标志,需综合评估多病共存。
  • ILA的预后意义与常见慢性病相当,提示需加强随访管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Interstitial lung abnormalities (ILAs) are associated with increased mortality. It is unclear whether multimorbidity accounts for the mortality association or how strongly ILA is associated with mortality relative to other common age-associated diseases. We determined the association of ILA with all-cause mortality adjusted for multimorbidity, compared mortality associated with ILA and prevalent cardiovascular disease (CVD), diabetes mellitus, chronic kidney disease, chronic obstructive pulmonary disease and cancer and also determined the association between ILA and these diseases. METHODS: We measured ILA (none, indeterminant, definite) using blinded reads of CT images, prevalent chronic diseases and potential confounders in two observational cohorts, the Framingham Heart Study (FHS) (n=2449) and Age, Gene/Environment Susceptibility - Reykjavik Study (AGES-Reykjavik) (n=5180). We determined associations with mortality using Cox proportional hazards models and between ILA and diseases with multinomial logistic regression. RESULTS: Over a median (IQR) follow-up of 8.8 (1.4) years in FHS and 12.0 (7.7) years in AGES-Reykjavik, in adjusted models, ILAs were significantly associated with increased mortality (HR, 95% CI 1.95, 1.23 to 3.08, p=0.0042, in FHS; HR 1.60, 1.41 to 1.82, p<0.0001, in AGES-Reykjavik) adjusted for multimorbidity. In both cohorts, the association of ILA with mortality was of similar magnitude to the association of most other diseases. In adjusted models, ILAs were associated only with prevalent kidney disease (OR, 95% CI 1.90, 1.01 to 3.57, p=0.0452) in FHS and with prevalent CVD (OR 1.42, 1.12 to 1.81, p=0.0040) in AGES-Reykjavik. CONCLUSIONS: ILAs were associated with mortality adjusted for multimorbidity and were similarly associated with increased mortality compared with several common chronic diseases. ILAs were not consistently associated with the prevalence of these diseases themselves.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Sanders JL, Axelsson G, Putman R, et al. The relationship between interstitial lung abnormalities, mortality, and multimorbidity: a cohort study. Thorax. 2022. PMID: 35777957. doi:10.1136/thoraxjnl-2021-218315

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。